Ironwood Pharmaceuticals Inc (IRWD)
Gross profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 245,368 | 287,184 | 269,126 | 194,925 | 167,020 |
| Revenue | US$ in thousands | 421,125 | 403,178 | 381,332 | 353,446 | 366,965 |
| Gross profit margin | 58.26% | 71.23% | 70.58% | 55.15% | 45.51% |
December 31, 2023 calculation
Gross profit margin = Gross profit ÷ Revenue
= $245,368K ÷ $421,125K
= 58.26%
Ironwood Pharmaceuticals Inc has consistently maintained a high gross profit margin over the past five years, with figures ranging from 94.43% in 2019 to 100.00% in the subsequent years. This indicates the company's efficiency in managing its production costs and pricing strategies to generate profits from its core business operations. The stability and strength of the gross profit margin suggest that Ironwood has been effectively controlling its cost of goods sold while maximizing revenue generation. Overall, the trend reflects positively on the company's operational performance and indicates a healthy financial position.
Peer comparison
Dec 31, 2023